Aptimmune Biologics has created a series of advanced enabling technologies which provide solutions to today's most challenging and economically important swine diseases.
Using the BarricadeR platform technology, we have empowered stakeholders to address the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and Swine Influenza A virus (IAV-S) vaccine markets in multiple geographies. Additionally, our R&D is focused in creating vaccines against the highly contagious African Swine Fever virus (ASFV) for regions devastated by this disease.